¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"plasma cross matching"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • cross cylinder
    ±³Â÷¿øÁÖ·»Áî
  • cross fertilization
    ±³Â÷¼öÁ¤, Ÿ°¡¼öÁ¤
  • cross fire irradiation
    ½ÊÀÚÆ÷È­Á¶»ç
  • cross fire technique
    ½ÊÀÚÆ÷È­Á¶»ç¹ý
  • cross fixation
    ±³Â÷ÁÖ½Ã
  • cross flap
    ±³Â÷ÇÇÆÇ
  • cross foot
    ¾ÈÂʹøÁü¹ß, ³»¹øÁ·
  • cross heredity
    ±³Â÷À¯Àü
  • cross immunity
    ±³Â÷¸é¿ª
  • cross infection
    ±³Â÷°¨¿°
  • cross inheritance
    ±³Â÷À¯Àü
  • cross neutralization
    ±³Â÷ÁßÈ­
  • cross reactivation
    ±³Â÷ÀçȰ¼ºÈ­
  • cross relaxation
    ±³Â÷ÀÌ¿Ï
  • cross section radiography
    ´ÜÃþ¹æ»ç¼±ÃÔ¿µ(¼ú)
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • cross-binding
    ±³Â÷¿¬°á
  • cross-contamination
    ±³Â÷¿À¿°
  • cross-eye
    (¢¡esotropia) ³»»ç½Ã
  • cross-face
    ±³Â÷¾ó±¼
  • cross-finger
    ±³Â÷Áö-, ¼Õ°¡¶ô±³Â÷
  • cross-leg
    Á¾¾Æ¸®±³Â÷-, ÇÏÅð±³Â÷-
  • cross-linking
    ±³Â÷°áÇÕ
  • cross-plate
    ±³Â÷ÆÇ
  • cross-protection
    ±³Â÷¹æ¾î
  • cross-reaction
    ±³Â÷¹ÝÀÀ
  • cross-reactivity
    ±³Â÷¹ÝÀÀ¼º
  • cross-resistance
    ±³Â÷ÀúÇ×
  • cross-section
    °¡·Î´Ü¸é
  • cross-talk
    ±³Â÷´ëÈ­
  • cross-tolerance
    ±³Â÷³»¼º
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • plasma clot
    Ç÷À屫(úìíìÎÔ)
  • plasma coagulation factor
    Ç÷ÀåÀÀ°íÀÎÀÚ
  • plasma component transfusion
    Ç÷À强ºÐ¼öÇ÷
  • plasma concentration
    Ç÷Àå³óµµ.
  • plasma exchange
    Ç÷À屳ȯ
  • plasma exchange
    Çö󽺸¶±³È¯(¡­Îßüµ)
  • plasma exchange = plasmapheresis
    Ç÷À屳ȯ, Ç÷À强ºÐäÁý¼ú
  • plasma expander =p. volume e.
    ´ë¿ëÇöóÁ<Ç÷Àå>, ÇöóÁ<Ç÷Àå(úìíì )>Áõ·®Á¦(¡­ñòåÖð¥).
  • plasma factor
    Ç÷ÀåÀÎÀÚ(úìíìì×í­), ÇöóÁÀÎÀÚ.
  • plasma factor
    Ç÷ÀåÀÎÀÚ(úìíìì×í­), ÇöóÁÀÎÀÚ(¡­ì×í­)
  • plasma globulin
    ÇöóÁ±Û·ÎºÒ¸°, Ç÷Àå±Û·ÎºÒ¸°.
  • plasma hemoglobin
    Ç÷ÀåÇì¸ð±Û·Îºó, Ç÷ÀåÇ÷¾×¼Ò.
  • plasma histaminase activity
    Ç÷ÀåÈ÷½ºÅ¸¹Ì³ª¾ÆÁ¦È°¼ºµµ.
  • plasma hydrolysate
    Ç÷Àå°¡¼öºÐÇØ¹°(¡­Ê¥â©ÝÂú°Úª).
  • plasma iron
    Ç÷Àåö(úìíìôÑ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • cross match test
    ±³Â÷½ÃÇè(¡­ãËúÐ).
  • cross neutralization
    ±³Â÷ÁßÈ­ÀÛ¿ë(¡­ñéûúíÂéÄ).
  • cross over value
    ±³Â÷°ª.
  • cross protection
    È¥¼±¹æÁö(Ì´ËÛËÑ̤), ±³Â÷º¸È£(˴̤ËÓÌ´), ±³Â÷¹æ¾î(·Â)(Ë´ ̤ËÑËâËç).
  • cross reacting antibody
    ±³Â÷¹ÝÀÀÇ×ü(¡­ù÷ô÷).
  • cross reaction
    ±³Â÷¹ÝÀÀ(Îßó©Úãëë).
  • cross reactivation
    ±³Â÷ÀçȰ¼ºÈ­(¡­üÀàõûù).
  • cross reactivation
    ±³Â÷Ȱ¼ºÈ¸º¹.[»ýÈ­]±³Â÷Ȱ¼ºÈ­(¡­üÀàõûù).
  • cross reactivation
    ±³Â÷Ȱ¼ºÈ¸º¹.[»ýÈ­]±³Â÷Ȱ¼ºÈ­(¡­üÀàõûù).
  • cross reactivation
    ±³Â÷ÀçȰ¼ºÈ­
  • cross reactive antibody
    ±³Â÷¹ÝÀÀÇ×ü
  • cross reactive antigen
    ±³Â÷¹ÝÀÀÇ׿ø
  • cross reactivity
    ±³Â÷¹ÝÀÀ¼º.
  • cross reactivity
    ±³Â÷ ¹ÝÀÀ
  • cross relaxation
    ±³Â÷ ÀÌ¿Ï
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • cross tolerance
    ±³Â÷³»¼º(Îßó©Ò±àõ)
  • genetic cross
    À¯Àü ±³Â÷(ë¶îîÎßó©)
  • helical cross
    ³ª¼± ½ÊÀÚ(Õ¢àÁä¨í®)
  • phage cross
    ÆäÀÌÁö ±³Â÷(Îßó©)
  • photoactivated cross-linking
    ±¤ºÎȰ ±³Â÷ ¿¬°á(ÎÃÝ¥üÀÎßó©Ö§Ì¿)
  • three-factor cross
    »ïÀÎÀÚ ±³Â÷ (ß²ì×í­Îßó©)
  • three-point cross
    ¼¼Á¡ ±³Â÷(Îßó©)
  • two-factor cross
    ÀÌÀÎÀÚ ±³Â÷(ì£ì×í­Îßó©)
  • two-point cross
    ÀÌÁ¡±³Â÷(ì£ïÇÎßó©)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
ANRC American National Red Cross
ARC accelerating rate calorimetry; acquired immunodeficiency syndrome-related complex; active renin conc...
ARRC Associate of the Royal Red Cross
BC Bachelor of Surgery [Lat. Baccal-aureus Chirurgiae]; back care; bactericidal concentration; basal ce...
BCA balloon catheter angioplasty; bicinchoninic acid; blood color analyzer; Blue Cross Association; bran...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
CCH Cross-correlation histograms
CP Cross-polarization
CRM Cross-reacting material
CRI Cross-reactive idiotypes
X-SA Cross-sectional area
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • cross-allergy
    ±³Â÷ ¾Ë·¹¸£±â
    ¸î¸î ±³Â÷ ¹ÝÀÀÇÏ´Â Ç׿ø¿¡ ´ëÇÑ ¾Ë·¹¸£±â¼º ¹ÝÀÀ. ÇÑ ¼ººÐ¿¡ ¾Ë·¯Áö ¹ÝÀÀÀÌ Àִ ȯÀÚ´Â ´Ù¸¥ À¯»çÇÑ ¼ººÐ¿¡µµ ¾Ë·¯Áö ¹ÝÀÀÀÌ ÀÖ´Â °æÇâÀÌ ÀÖ´Ù´Â »ç½Ç.
  • cross-eye
    »ç½Ã, ³»»ç½Ã
  • cross-linkage
    ±³Â÷ °áÇÕ
  • cross-match
    ±³Â÷ ÀûÇÕ
  • cross-over position
    ¹Ý´ëÀ§
  • cross-reactivity
    ±³Â÷ ¹ÝÀÀ¼º
  • cross-section
    Ⱦ´Ü ¸é
    ¾î´À ½ÃÆíÀÇ ³»ºÎ¸¦ °üÂûÇϱâ À§ÇÏ¿© ÀϹÝÀûÀ¸·Î Á߽ɺθ¦ Ⱦ´Ü½ÃÄÑ °¡·Î ¶Ç´Â ¼¼·Î·Î ÀÚ¸¥ ¸é.
  • cross-sectional sample
    ȾÀûÀÎ °æ¿ì
  • cross-sectional study
    Ⱦ´Ü ¿¬±¸¹ý, Ⱦ´Ü Á¶»ç¹ý
  • posterior cross bite
    ±¸Ä¡ ¹Ý´ë±³ÇÕ, ±¸Ä¡ºÎ ¹Ý´ë±³ÇÕ
  • sagittal cross section
    ½Ã»ó´Ü
    ½Ã»ó¸é
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
apical plasma membrane <cell biology> The term used for the cell membrane on the apical (inner or upper) surface of transporting epithelial cells.
This region of the cell membrane is separated, in vertebrates, from the baso lateral membrane by a ring of tight junctions that prevents free mixing of membrane proteins from these two domains.
(18 Nov 1997)
basolateral plasma membrane <cell biology> The plasma membrane of epithelial cells that is adjacent to the basal lamina or the adjoining cells of the sheet. Differs both in protein and phospholipid composition from the apical plasma membrane from which it is isolated by tight junctions (zonula occludentes).
(18 Nov 1997)
beam-plasma reaction <radiobiology> Fusion reaction which occurs from the collision of a fast beam ion with a thermal plasma ion.
(09 Oct 1997)
bean-shaped plasma <radiobiology> A toroidal plasma indented on the inboard side (the side with the donut hole), that results in additional stability to ballooning modes. Moderate indentation may provide access to the second-stability region (high beta).
(13 Nov 1997)
blood plasma <haematology> Acellular fluid in which blood cells are suspended. Serum obtained by defibrinating plasma (plasma derived serum) lacks platelet released factors and is less suitable to support the growth of cells in culture.
(13 Oct 1997)
blood plasma fractions Portions of the blood plasma as separated by electrophoresis or other technique.
(05 Mar 2000)
rapid plasma reagin <investigation> The rapid plasma reagin test is similar to the VDRL test for diagnosing syphilis. This blood test is designed to detect an antibody substance in the bloodstream when syphilis infection is present. Early syphilis infections may be RPR negative.
See: VDRL
(17 Dec 1997)
rapid plasma reagin test A group of serologic test's for syphilis in which unheated serum or plasma is reacted with a standard test antigen containing charcoal particles; positive test's yield a flocculation. A modification, called the RPR (circle) card test, is widely used as a screening test.
Synonym: RPR test.
(05 Mar 2000)
renal plasma flow <physiology> The amount of plasma that perfuses the kidneys per unit time, approximately 10% greater than effective renal plasma flow.
It should be differentiated from the renal blood flow which refers to the total volume of blood flowing through the renal vasculature, while the renal plasma flow refers to the rate of plasma flow.
(12 Dec 1998)
peak plasma drug concentration <pharmacology> The highest level of drug that can be obtained in the blood usually following multiple doses.
(09 Oct 1997)
granuloma, plasma cell A slow-growing benign pseudotumour in which plasma cells greatly outnumber the inflammatory cells.
(12 Dec 1998)
granuloma, plasma cell, orbital A distinctive, chronic inflammatory reaction in the orbital tissues of the eye, of unknown aetiology, that may closely resemble a neoplasm and often becomes bilateral. Symptoms include exophthalmos and congestion of the lids with oedema. When limitation of ocular motility also occurs, it is sometimes called orbital myositis.
(12 Dec 1998)
granuloma, plasma cell, pulmonary A pseudotumour of the lung composed of inflammatory cells and showing complete maturity of fibroblastic components with a striking lack of mitosis. It is also called postinflammatory pseudotumour and pseudoneoplastic pneumonitis. (berardi, r.s. Et al. Inflammatory pseudotumours of the lung. Surg gynecol obstet 156:89-96, jan 83)
(12 Dec 1998)
collisionless plasma model <radiobiology> Model of a plasma in which the density is so low, or the temperature so high, that close binary (two-body) collisions have practically no significance (on certain timescales) because the time scales of interest are shorter than the collision time. Yields valid physical results for timescales much shorter than the average collision time in a real plasma.
(09 Oct 1997)
plasma <haematology> Acellular fluid in which blood cells are suspended. Serum obtained by defibrinating plasma (plasma derived serum) lacks platelet released factors and is less suitable to support the growth of cells in culture.
(13 Oct 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • cross sea
    ³î;¿ªÇ³¶û
  • cross section
    °¡·ÎÀÚ¸£±â;Ⱦ´Ü¸é;´Ü¸éµµ;(»çȸ µîÀÇ)´ëÇ¥ÀûÀÎ ¸é;´Ü¸é
  • cross selling
    »óÈ£ÆÇ¸Å;³¢¿ö ÆÈ±â(¿µÈ­¿Í ±× ·¹ÄÚµå.¿øÀÛº» µîÀ»)µ¿½Ã¿¡ ÆÈ±â
  • cross shot
    Å©·Î½º ¼ô(È­¸é¿¡ ´ëÇØ¼­ ºñ½ºµëÈ÷ ÂïÀº È­»ó);ÄÚÆ®ÀÇ ´ë°¢¼±À¸·Î Ä¡´Â °ø A
  • cross street
    ±³Â÷·Î;(Å« ±æ°ú ±³Â÷µÇ´Â)°ñ¸ñ±æ
  • cross talk
    È¥¼±;È¥½Å;¸»´ÙÅù;¾ðÀï;(ÀÇȸ¿¡¼­)´çÆÄ°£ÀÇ ¸»ÀÇ ÀÀ¼ö;(Èñ±Ø¹è¿ìÀÇ)ÀÀ¼ö
  • cross-armed
    ÆÈÀåÀ» ³¤;°¡·ÎÀåÀ» ´í
  • cross-busing
    ¹éÀÎ.ÈæÀÎ ÇлýÀÇ °øµ¿ ¹ö½º ÅëÇÐ
  • cross-buttock
    Ç㸮ġ±â(¸¦ ÇÏ´Ù)
  • cross-channel
    ÇØÇùȾ´ÜÀÇ;ÇØÇùÀÇ ¸ÂÀº Æí ÂÊÀÇ(ƯÈ÷ ¿µ±¹ ÇØÇùÀÇ)
  • cross-check
    (¿©·¯ ÀڷḦ)ºñ±³ °ËÅäÇÏ´Ù;´Ù¸¥ °¢µµ¿¡¼­ °ËÁõÇÏ´Ù;Å©·Î½ºÃ¼Å©ÇÏ´Ù;Á¤È®µµ °ËÅä;Å©·Î½ºÃ¼Å©
  • cross-country
    »ê¾ß¸¦ Ⱦ´ÜÇÏ´Â;Å©·Î½ºÄÁÆ®¸® °æ±â
  • cross-cultural
    ºñ±³¹®È­ÀÇ;À̹®È­°£ÀÇ
  • cross-disciplinary
    ÇÐÁ¦ÀûÀÎ;Á¦Çй®ÀÌ Á¦ÈÞÇÏ´Â
  • cross-dress
    À̼ºÀÇ ¿ÊÀ» ÀÔ´Ù
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á